Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Alembic Pharma gets 4 observation by USFDA for Panelav facility

      Alembic Pharma gets 4 observation by USFDA for Panelav facility

      Medical Dialogues Bureau27 Oct 2018 10:00 AM IST
      Gets 4 procedural observations under Form 483New Delhi: Alembic Pharma through a recent regulatory filing announced that the United States Food and...
      Why DRUG PRICES are High: CCI Policy Paper on Healthcare

      Why DRUG PRICES are High: CCI Policy Paper on Healthcare

      Medical Dialogues Bureau27 Oct 2018 10:00 AM IST
      Competition Commission of India Brings Out Policy Note on ‘Making Markets Work for Affordable Healthcare’New Delhi: The Competition Commission of...
      Gilead hepatitis C drug sales fall, but profit beats estimates

      Gilead hepatitis C drug sales fall, but profit beats estimates

      Medical Dialogues Bureau27 Oct 2018 9:10 AM IST
      Gilead, which announced in July that Chief Executive Officer John Milligan and Chairman John Martin would step down as soon as the end of the year,...
      Daiichi Announces Clinical Collaboration with Merck, Pfizer

      Daiichi Announces Clinical Collaboration with Merck, Pfizer

      Medical Dialogues Bureau27 Oct 2018 9:00 AM IST
      New Delhi: Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck KGaA, Darmstadt,...
      U.S. FDA declines to approved Eye drug Eylea

      U.S. FDA declines to approved Eye drug Eylea

      Medical Dialogues Bureau27 Oct 2018 9:00 AM IST
      Regeneron also said Eylea met the main goal in a late-stage trial testing it in patients with moderately severe and severe diabetic retinopathy, an...
      Dont Eat The News: Religare Health Insurance launches awareness campaign on slow poisoning

      Don't Eat The News: Religare Health Insurance launches awareness campaign on slow poisoning

      Medical Dialogues Bureau26 Oct 2018 2:12 PM IST
      Consumption of food items wrapped in newspapers may have hazardous impact.New Delhi: The Food Safety and Standards Authority of India (FSSAI) recently...
      Hypoglycaemia, Mental Health Side Effects: Label side-effect warnings of Fluoroquinolone, DCGI tells Drugmakers

      Hypoglycaemia, Mental Health Side Effects: Label side-effect warnings of Fluoroquinolone, DCGI tells Drugmakers

      Medical Dialogues Bureau26 Oct 2018 11:04 AM IST
      Fluoroquinolones are antibiotics used to treat respiratory and urinary tract infections. These medicines include ciprofloxacin, gemifloxacin,...
      Moves JPMorgan reshuffles healthcare group, co-head departs

      Moves JPMorgan reshuffles healthcare group, co-head departs

      Medical Dialogues Bureau26 Oct 2018 9:45 AM IST
      JPMorgan has advised on some of the largest healthcare deals this year, including Takeda Pharmaceutical’s pending $62 billion agreement to buy...
      Wipro sees challenges in US healthcare biz amid Obamacare uncertainties

      Wipro sees challenges in US healthcare biz amid Obamacare uncertainties

      Medical Dialogues Bureau26 Oct 2018 9:25 AM IST
      Mumbai: Indian software services exporter Wipro Ltd has recently announced that its healthcare services business in the United States as a challenge...
      FDA approved marketing of a diagnostic test to aid in the determination of menopausal status

      FDA approved marketing of a diagnostic test to aid in the determination of menopausal status

      Medical Dialogues Bureau26 Oct 2018 9:20 AM IST
      New Delhi: The FDA granted marketing authorization of the PicoAMH Elisa test to Ansh Labs. The U.S. Food and Drug Administration permitted the...
      US approves first new type of flu drug in 2 decades

      US approves first new type of flu drug in 2 decades

      Medical Dialogues Bureau26 Oct 2018 9:00 AM IST
      TRENTON, N.J: U.S. health regulators have approved the first new type of flu drug in two decades.Wednesday's approval of Xofluzafor people age 12 and...
      Sale of spurious cosmetics: DCGI issues notice to Amazon, Flipkart

      Sale of spurious cosmetics: DCGI issues notice to Amazon, Flipkart

      Medical Dialogues Bureau25 Oct 2018 11:41 AM IST
      Asking the companies to reply to its notice within 10 days, the DGCI has warned them of penal action for "offering for sale, sale and distribution of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok